{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intervention+2+-+Placebo&page=5", "query": { "intervention": "Intervention 2 - Placebo", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 1494, "total_pages": 150, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intervention+2+-+Placebo&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intervention+2+-+Placebo&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T10:48:24.069Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06720909", "title": "Mindfulness And Placebo for Pain (MAPP) Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain" ], "interventions": [ { "name": "Mindfulness-Based Stress Reduction (MBSR)", "type": "BEHAVIORAL" }, { "name": "Open-Label Placebo (OLP)", "type": "OTHER" }, { "name": "MBSR+OLP", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Arizona State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2025-01-27", "completion_date": "2027-03-01", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 2, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06720909" }, { "nct_id": "NCT04129931", "title": "PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "MCT", "type": "DRUG" }, { "name": "Clazakizumab", "type": "DRUG" }, { "name": "Broncho-Vaxom", "type": "DRUG" }, { "name": "Imatinib Mesylate", "type": "DRUG" }, { "name": "Cavosonstat", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 950, "start_date": "2019-12-19", "completion_date": "2025-03-19", "has_results": true, "last_update_posted_date": "2026-04-01", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 29, "location_summary": "Scottsdale, Arizona • Tucson, Arizona • Sacramento, California + 17 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04129931" }, { "nct_id": "NCT04006392", "title": "An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Peripheral Neuropathy" ], "interventions": [ { "name": "Erchonia FX-635", "type": "DEVICE" }, { "name": "Placebo Laser", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Erchonia Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2019-02-15", "completion_date": "2021-10-05", "has_results": true, "last_update_posted_date": "2023-03-14", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 4, "location_summary": "Mesa, Arizona • Costa Mesa, California • Hialeah, Florida + 1 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Florham Park", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04006392" }, { "nct_id": "NCT05422612", "title": "Department of Defense PTSD Adaptive Platform Trial - Master Protocol", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post Traumatic Stress Disorder" ], "interventions": [ { "name": "Intervention A Fluoxetine Hydrochloride (HCl)", "type": "DRUG" }, { "name": "Intervention A Placebo", "type": "DRUG" }, { "name": "Intervention B Vilazodone Hydrochloride (HCl)", "type": "DRUG" }, { "name": "Intervention B Placebo", "type": "DRUG" }, { "name": "Intervention C Daridorexant", "type": "DRUG" }, { "name": "Intervention C Placebo", "type": "DRUG" }, { "name": "Intervention D SLS-002", "type": "DRUG" }, { "name": "Intervention D Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Global Coalition for Adaptive Research", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 800, "start_date": "2023-11-02", "completion_date": "2029-07", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 9, "location_summary": "Miami, Florida • Atlanta, Georgia • Tripler AMC, Hawaii + 6 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Tripler AMC", "state": "Hawaii" }, { "city": "Fort Thomas", "state": "Kentucky" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05422612" }, { "nct_id": "NCT01226563", "title": "IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Myocardial Infarction", "Congestive Heart Failure", "ST-Elevation Myocardial Infarction" ], "interventions": [ { "name": "IK-5001", "type": "DEVICE" }, { "name": "Saline Solution", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Bellerophon BCM LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 303, "start_date": "2012-04", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2023-02-27", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Torrance, California • Washington D.C., District of Columbia + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Torrance", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01226563" }, { "nct_id": "NCT03231514", "title": "Determining the Ergogenic Effects of Carb10™ Supplementation on Carbohydrate-Rich and Carbohydrate-Restricted Diets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ketogenic Dieting" ], "interventions": [ { "name": "Carbohydrate Supplement (Carb10)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Diet", "type": "OTHER" }, { "name": "Exercise", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Texas Woman's University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 59, "start_date": "2017-01", "completion_date": "2017-12", "has_results": false, "last_update_posted_date": "2018-02-20", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 1, "location_summary": "Denton, Texas", "locations": [ { "city": "Denton", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03231514" }, { "nct_id": "NCT05004506", "title": "Intra-articular Analgesia Versus Adductor Canal Block for Arthroscopic Knee Surgery", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Post-Operative Pain, Chronic" ], "interventions": [ { "name": "Adductor Canal Block", "type": "DRUG" }, { "name": "Intra-articular Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loyola University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 100, "start_date": "2016-04-20", "completion_date": "2022-12-31", "has_results": false, "last_update_posted_date": "2022-04-12", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 1, "location_summary": "Maywood, Illinois", "locations": [ { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05004506" }, { "nct_id": "NCT05503264", "title": "A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "NMDAR Autoimmune Encephalitis", "LGI1 Autoimmune Encephalitis" ], "interventions": [ { "name": "Satralizumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 122, "start_date": "2022-09-27", "completion_date": "2028-12-14", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Newport Beach, California • San Francisco, California + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05503264" }, { "nct_id": "NCT03229174", "title": "Brain Perfusion & Oxygenation in Parkinson's Disease With NOH", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Parkinson Disease", "Neurogenic Orthostatic Hypotension" ], "interventions": [ { "name": "Droxidopa", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "William Ondo, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 17, "start_date": "2018-08-23", "completion_date": "2022-02-02", "has_results": false, "last_update_posted_date": "2022-09-06", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03229174" }, { "nct_id": "NCT00521196", "title": "Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "DC Stimulator (Transcranial Direct Current Stimulator)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 13, "start_date": "2007-07", "completion_date": "2012-01-13", "has_results": false, "last_update_posted_date": "2017-03-21", "last_synced_at": "2026-11-15T10:48:24.069Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00521196" } ] }